Editorial
doi: 10.1001/jama.2014.5993.
Thrombolytic therapy for pulmonary embolism
Affiliations
- PMID: 24938561
- DOI: 10.1001/jama.2014.5993
Item in Clipboard
Editorial
Thrombolytic therapy for pulmonary embolism
JAMA.
.
No abstract available
Comment on
-
Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.JAMA. 2014 Jun 18;311(23):2414-21. doi: 10.1001/jama.2014.5990. JAMA. 2014. PMID: 24938564
Similar articles
-
Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding.Ann Intern Med. 2014 Sep 16;161(6):JC8-9. doi: 10.7326/0003-4819-161-6-201409160-02009. Ann Intern Med. 2014. PMID: 25222421 No abstract available.
-
Benefits and risks associated with thrombolysis for pulmonary embolism.JAMA. 2014 Oct 15;312(15):1589. doi: 10.1001/jama.2014.10786. JAMA. 2014. PMID: 25321915 No abstract available.
-
Benefits and risks associated with thrombolysis for pulmonary embolism.JAMA. 2014 Oct 15;312(15):1588-9. doi: 10.1001/jama.2014.10780. JAMA. 2014. PMID: 25321914 No abstract available.
-
Pulmonary embolism: whom to discharge and whom to thrombolyze?J Thromb Haemost. 2015 Jun;13 Suppl 1:S252-8. doi: 10.1111/jth.12944. J Thromb Haemost. 2015. PMID: 26149032 Review.
-
Treatment of pulmonary embolism: anticoagulation, thrombolytic therapy, and complications of therapy.Crit Care Clin. 2011 Oct;27(4):825-39, vi. doi: 10.1016/j.ccc.2011.08.002. Epub 2011 Sep 29. Crit Care Clin. 2011. PMID: 22082516 Review.
Cited by
-
The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta-analysis.EJHaem. 2020 Sep 3;1(2):457-466. doi: 10.1002/jha2.97. eCollection 2020 Nov. EJHaem. 2020. PMID: 35844995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
